Menu
Skills in this repository
SkillsMP has collected 858 skills from dromlakhani/MD2SKILL. Open a skill to review its source and details.
dromlakhani/MD2SKILLShowing 40 of 858 collected skills.
Suggests targeting preoperative blood glucose concentrations of 100–180 mg/dL when achieving HbA1c <8% is not feasible prior to elective surgery. Use when a clinician faces upcoming surgery with insufficient time to lower HbA1c below 8%.
Recommends targeting preoperative HbA1c <8% and blood glucose 100–180 mg/dL in adults with diabetes undergoing elective surgery. Use when scheduling elective surgery in a diabetic patient or reviewing HbA1c or point-of-care glucose.
Recommends scheduled insulin therapy over noninsulin agents for glycemic management in most adult hospitalized patients with hyperglycemia (with or without known type 2 diabetes) during noncritical illness. Trigger phrases include new hyperglycemia without…
This skill advises against routine insulin infusion in patients without diabetes who have triglyceride-induced pancreatitis. Trigger phrases include "Patient has triglyceride-induced pancreatitis without diabetes" and "Considering insulin infusion for…
The guideline recommends against using lipid-lowering therapies to treat hyperandrogenism or infertility in women with polycystic ovary syndrome. Consider this recommendation when encountering a PCOS patient with infertility concerns, when considering lipid…
This skill recommends against using acute plasmapheresis as first-line therapy to lower triglycerides in triglyceride-induced pancreatitis. Trigger phrases include "Patient presents with triglyceride-induced pancreatitis" and "Considering plasmapheresis for…
Suggests against treating hyperlipidemia until the patient becomes euthyroid in order to more accurately assess the lipid profile in patients with overt hypothyroidism. Triggers include: "Patient with overt hypothyroidism and hyperlipidemia", "Considering…
Recommends assessing 10-year atherosclerotic cardiovascular disease risk using the Pooled Cohort Equations to guide lipid-lowering therapy initiation in adults with obesity. Triggers include obese patient needing lipid-lowering therapy decision, assessing…
Recommends conducting cardiovascular risk assessment by evaluating traditional risk factors and calculating 10-year atherosclerotic cardiovascular disease risk using the Pooled Cohort Equations. Use when a clinician asks about cardiovascular risk…
This skill suggests assessment and treatment of lipids and other cardiovascular risk factors in adults receiving chronic glucocorticoid therapy above replacement levels due to increased cardiovascular disease risk. Clinical triggers include "Patient on…
Recommends assessment and treatment of lipids and other cardiovascular risk factors in women who enter menopause early (<40 to 45 years old), with atherosclerotic cardiovascular disease risk calculated and followed after menopause. Clinical triggers include:…
Suggests assessment and treatment of lipids and other cardiovascular risk factors in adults with growth hormone deficiency associated with hypopituitarism. Trigger phrases include: "GHD with hypopituitarism needing lipid management", "Assessing cardiovascular…
Suggests measuring coronary artery calcium to inform shared decision-making when statin treatment decisions are uncertain in adults with endocrine disorders at borderline or intermediate ASCVD risk. Triggers include patient has 10-year ASCVD risk between…
Advises clinical or biochemical investigation for anabolic steroid abuse when encountering isolated low HDL‑C (<30 mg/dL) without elevated triglycerides. Typical triggers include a patient with HDL‑C <30 mg/dL and normal TG, suspected anabolic steroid use…
Suggests considering thyroxine treatment to reduce LDL-C in patients with subclinical hypothyroidism (TSH <10 mIU/L) and associated hyperlipidemia. Trigger phrases include "Patient with SCH and hyperlipidemia", "TSH between 4-10 mIU/L with elevated lipids",…
The guideline recommends that cardiovascular risk assessment and management in adults with cured Cushing syndrome follow the same approach as in the general population. Clinical triggers include evaluating a patient with cured Cushing syndrome, performing…
The guideline suggests adding eicosapentaenoic acid ethyl ester 4 g/day to reduce cardiovascular disease risk in adults on statins with persistent triglyceride levels 150–499 mg/dL who have either established atherosclerotic cardiovascular disease or type 2…
Suggests adding eicosapentaenoic acid ethyl ester 4 g/day to reduce cardiovascular risk in adults with type 2 diabetes on a statin at LDL goal with residual triglycerides over 150 mg/dL and two additional traditional or risk-enhancing factors. Triggers…
Recommends obtaining a fasting screening lipid panel at diagnosis to assess cardiovascular risk in women with polycystic ovary syndrome. Triggers include: "New PCOS diagnosis", "Initial lipid assessment in ovarian disorder", "Baseline cardiovascular risk…
Suggests fibrates in addition to statins to reduce retinopathy progression in adults with type 2 diabetes and diabetic retinopathy. Triggers include: "Patient with T2D and diabetic retinopathy", "Considering fibrate for retinopathy protection", "Assessing…
Recommends choosing high-intensity statins in patients with atherosclerotic cardiovascular disease, or those with risk factors for atherosclerotic cardiovascular disease or risk-enhancing factors. Trigger phrases include: "Patient with established ASCVD",…
Recommends LDL-C goal <55 mg/dL in patients with established ASCVD or multiple risk factors to reduce cardiovascular risk. Triggers include: patient with established ASCVD, high-risk patient needing aggressive lipid lowering, assessing LDL-C target in…
Recommends lowering LDL-C to <70 mg/dL in adults with type 2 diabetes and cardiovascular risk factors to reduce ASCVD risk. Consider when encountering a patient with T2D and CV risk factors, LDL-C >70 mg/dL requiring treatment, or when assessing…
Suggests lifestyle measures as first-line treatment for obese patients with elevated triglycerides to lower cardiovascular and pancreatitis risk. Applies when considering first-line therapy for obesity-related hypertriglyceridemia or a non-pharmacological…
Recommends lipid profile measurement after bariatric surgery to assess cardiovascular risk in patients with obesity (BMI >40 or >35 kg/m2 with comorbidities). Clinical triggers include: patient post-bariatric surgery needing lipid assessment, assessing…
Recommends obtaining a lipid panel to assess triglyceride levels and calculate LDL-C for initial screening in adults with endocrine disorders. Triggered when a clinician requests initial lipid assessment in a patient with known endocrine disorder such as…
Reassesses lipid profile after 5% weight loss in obese patients on pharmacological weight loss therapy to evaluate cardiovascular disease and pancreatitis risk.
Defines lipoprotein(a) ≥50 mg/dL (125 nmol/L) as a cardiovascular risk-enhancing factor for atherosclerotic cardiovascular disease. Triggered by Lp(a) measurement showing ≥50 mg/dL, assessing Lp(a)'s contribution to CVD risk, or using the Lp(a) threshold for…
Suggests measuring lipoprotein(a) to inform decision-making about short-term and lifetime ASCVD risk and need to intensify LDL-C-lowering therapy in adult patients with family history of premature ASCVD, personal history of ASCVD, or family history of high…
Suggests measurement of the usual lipid profile before and after treatment of growth hormone excess in adults with acromegaly. Triggers include: patient with acromegaly starting treatment, assessing lipid changes after GH suppression therapy, lipid monitoring…
Advises assessment of metabolic syndrome components and body fat distribution to accurately determine cardiovascular disease risk in individuals with obesity. Trigger phrases include "Patient with obesity needing CVD risk assessment", "Evaluating metabolic…
Recommends monitoring the lipid profile at diagnosis and periodically thereafter to identify dyslipidemia in adult patients with Cushing syndrome. Triggered by phrases such as "Patient diagnosed with Cushing syndrome", "Assessing for lipid abnormalities in…
Recommends obtaining a lipid profile at diagnosis to assess for dyslipidemia in adults with growth hormone deficiency. Trigger phrases include "New diagnosis of GHD", "Initial lipid assessment in growth hormone disorder", and "Baseline lipid profile in…
Recommends pharmacologic treatment as adjunct to diet and exercise to prevent pancreatitis in adults with fasting triglyceride levels >500 mg/dL. Triggered when evaluating a patient with an endocrine disorder who presents with fasting TG >500 mg/dL (severe…
Suggests plasmapheresis may be useful in patients who do not respond to conventional triglyceride-lowering methods, such as those with triglyceride levels over 10,000 mg/dL or in extremely high-risk situations like pregnancy. Triggers include: "TG >10,000…
Recommends re-evaluating the lipid panel after a hyperthyroid patient becomes euthyroid, as LDL-C changes can appear as early as 3 months post-euthyroid. Trigger phrases include "Hyperthyroid patient becoming euthyroid", "Assessing lipid changes after thyroid…
Rules out hypothyroidism as a secondary cause of hyperlipidemia prior to initiating lipid-lowering therapy. Triggered by patient presentation with hyperlipidemia, consideration of starting lipid-lowering medication, or assessment of secondary causes of…
Advises that continuation or initiation of statin treatment in patients over 75 years depends on atherosclerotic cardiovascular disease risk, prognosis, potential interacting medications, polypharmacy, mental health, and patient wishes. Common clinical…
Recommends against using statins in women who are pregnant or trying to become pregnant. Trigger phrases include "Female patient of childbearing potential needing lipid therapy", "Assessing medication safety in pregnancy", "Considering statin for lipid…
Recommends dose adjustments for statins in chronic kidney disease, except for atorvastatin and fluvastatin which do not require dose adjustment. Triggers include: "Patient with CKD prescribed statin", "Assessing statin dosing in renal impairment", "Adjusting…